J. Ashton

Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.

J. Willerson, P. Golino, L. Buja, 1988, Circulation.

Serotonin S2 and thromboxane A2-prostaglandin H2 receptor blockade provide protection against epinephrine-induced cyclic flow variations in severely narrowed canine coronary arteries.

P. Golino, L. Buja, J. McNatt, 1989, Journal of the American College of Cardiology.

Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis.

J. Guerrero, J. Willerson, L. Buja, 1987, American heart journal.

Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase , serotonin receptors , and a-adrenergic receptors

W. Campbell, L. Buja, P. Apprill, 2022 .

Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase , serotonin receptors , and a-adrenergic receptors

L. Buja, P. Apprill, J. Schmitz, 2022 .

Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs.

J. Willerson, L. Buja, P. Apprill, 1985, Circulation.

LABORATORY INVESTIGATION

L. Buja, P. Apprill, G. Tilton, 2005 .